New Delhi: The World Health Organisation (WHO) has suspended the procurement of Covaxin, produced by Bharat Biotech, through UN agencies, NDTV reported. It said the step has been taken to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection.
The WHO clarified that the vaccine is effective and no safety concerns exist.
Hyderabad-based Bharat Biotech on Sunday said there is “no impact on efficacy and safety of Covaxin”. “For the millions who have received Covaxin, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine,” Bharat Biotech said in the statement, according to ANI.
WHO said the suspension followed an emergency use listing (EUL) inspection conducted from March 14 to 22.
Sonbhadra (UP): A man from Odisha’s Rourkela died and six others were injured when a… Read More
Bhubaneswar: Odisha Vigilance sleuths on Tuesday launched simultaneous searches at seven locations linked to Bidyadhar… Read More
Cuttack: The Orissa High Court has ruled that reservation policy cannot be made applicable for… Read More
Koraput: A tribal girl was allegedly gang-raped when she had gone to watch a jatra… Read More
Bhubaneswar: A speeding luxury car reportedly crashed into a house near Unit 4 Hospital Square… Read More
Bhubaneswar: In a tragic mishap, three youths were killed after a speeding car dashed against… Read More
This website uses cookies.
